Persist provides an AI‑powered formulation platform that combines proprietary, self‑improving models with robotics to accelerate the discovery of target product profiles. Users can run high‑throughput screening, receive AI‑driven predictions, and have their molecules designed, executed, and optimized from concept to in‑vivo‑ready formulation, all hosted on the customer’s cloud. The suite supports both self‑service and full‑service options, enabling formulation teams to scale expertise tenfold.
Funding
$12M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
1OSVFounders
Product
Problem
Formulating drug candidates into stable, effective dosage forms is time‑consuming and resource‑intensive, often requiring months of iterative testing and specialized expertise. Delays in achieving target product profiles increase development costs and extend time to market.
Solution
Persist offers an AI‑driven formulation platform that runs on the customer’s own cloud environment, continuously learning from each experiment to build a proprietary knowledge base. The platform integrates high‑throughput robotic screening labs to execute designs rapidly, enabling formulation teams to generate and evaluate dozens of candidates in parallel. By combining predictive AI models with automated synthesis and testing, Persist reduces the cycle from molecule to in‑vivo‑ready formulation by an order of magnitude. Clients can choose from a self‑service AI suite, a cloud lab execution service, or a full‑service option where Persist handles design, execution, and optimization end‑to‑end. The result is faster achievement of target product profiles, higher drug loading, extended release, and improved stability with significantly lower labor and material costs.
Target Audience
Primary customers are pharmaceutical and biotech companies that need rapid formulation development for small‑molecule, peptide, or complex drug candidates, as well as contract research organizations seeking to augment their formulation capabilities.
Features
- Self‑improving AI model deployed in the client’s cloud, creating a private, continuously updated formulation knowledge base
- High‑throughput robotic screening lab that automates formulation preparation, testing, and data capture
- End‑to‑end workflow options: AI‑only suite, cloud‑lab execution, or full‑service design‑execute‑optimize
- Predictive analytics that accelerate drug loading optimization, release profile tuning, and stability improvement
- Capability to handle diverse formulation types (nanoparticles, extended‑release, peptides, SEDDS, etc.) with rapid iteration cycles
- Secure data handling and integration with existing R&D infrastructure